SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
T/FIF Portfolio
An SI Board Since August 1998
Posts SubjectMarks Bans
1073 31 0
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
573 Rick, OXGN discontinues development of Neu-Sensamide: biz.yahoo.com You posRussian Bear-2/16/1999
572 Martin: Agree with most you said. However, we're getting slightly off-topscaram(o)uche-2/15/1999
571 We have to realise that, due to the,in general, biotech-adverse attitude of invJongmans-2/15/1999
570 Hi Richard, Ongoing concerns for third tier biotech's is and always will bBRAVEHEART-2/14/1999
569 Brian: I said: <i> largely dependent on lowering the margins for human scaram(o)uche-2/14/1999
568 My personal opinion is that (1) it is hard to be behind ENMD, and (2) there arescaram(o)uche-2/14/1999
567 Brian: I've got to stop responding on a stock-by-stock basis. To give a cscaram(o)uche-2/14/1999
566 >>...Genzyme Transgenics has not thrived. Many now consider it poised foMicawber-2/14/1999
565 Rick, thanks for your help and the lead to the other thread. I was sorely tempjeffbas-2/14/1999
564 Jeffrey: OK, I went ahead and read it...... Yes, biotechs burn money. That dscaram(o)uche-2/14/1999
563 Jeffrey: I'll respond to your other post in greater detail later. I startscaram(o)uche-2/14/1999
562 I used to, in the early days of SI, put a disclaimer, something like this, at tscaram(o)uche-2/14/1999
561 ReCap is a great resource. It is frequently off a bit or missing stuff, howevescaram(o)uche-2/14/1999
560 Thanks for your advice Steve. I was trying to get an informed point of view ojeffbas-2/13/1999
559 Jeffrey...be very careful about these biotech companies,particularly the fledglpuborectalis-2/13/1999
558 Richard, I took the trouble to find those VRGN posts and was impressed with youjeffbas-2/13/1999
557 Richard, Must be our error. Reacap shows CP-358,774 in PI only and Yahoo news 5,17,37,5,101,...-2/13/1999
556 I just got a strange private message here at SI. As most here know, I prefer tscaram(o)uche-2/13/1999
555 Regarding the MZ post is Collagenex's (CGPI) Metatstat a monoclonal antiboW PAUL-2/13/1999
554 Martin: I really appreciate your bringing up this question and addressing thesscaram(o)uche-2/12/1999
553 Jackson: I'm not as concerned about potential tox issues with C225. Howevscaram(o)uche-2/12/1999
552 Yes, a EGFr competitor. But CP-358 is way behind C225 which soon will be in PI5,17,37,5,101,...-2/12/1999
551 GLIA ask 26 7/8, buy 1K shares for "bounce". I haven't revised tscaram(o)uche-2/12/1999
550 Waaaay off topic now... I'd say there is a good chance that she is brightMike McFarland-2/12/1999
549 She *wants* to be a virologist? Yecko. Can't you convince her that graphiscaram(o)uche-2/11/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News